These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2745634)

  • 1. Determination of a disulfide-containing octapeptide antagonist of vasopressin in human plasma utilizing high-performance liquid chromatography with fluorescence detection.
    Rhodes GR; Rubenfield MJ; Garvie CT
    J Chromatogr; 1989 Mar; 488(2):456-62. PubMed ID: 2745634
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of an arginine-containing octapeptide antagonist of vasopressin in human plasma by means of a selective post-column reaction with fluorescence detection.
    Boppana VK; Rhodes GR
    J Chromatogr; 1990 May; 507():79-84. PubMed ID: 2380310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of vasopressin analogues by reversed-phase high-performance liquid chromatography.
    Lindeberg G
    J Chromatogr; 1980 May; 193(3):427-31. PubMed ID: 7380967
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor.
    Moore ML; Huffman WF; Roberts GD; Rottschaefer S; Sulat L; Stefankiewicz JS; Stassen F
    Biochem Biophys Res Commun; 1984 Jun; 121(3):878-83. PubMed ID: 6331433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a High-Sensitivity Quantitation Method for Arginine Vasopressin by High-Performance Liquid Chromatography Tandem Mass Spectrometry, and Comparison with Quantitative Values by Radioimmunoassay.
    Tsukazaki Y; Senda N; Kubo K; Yamada S; Kugoh H; Kazuki Y; Oshimura M
    Anal Sci; 2016; 32(2):153-9. PubMed ID: 26860558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tritiation of [8-L-arginine, 9-desglycineamide] vasopressin.
    Hrbas P; Cerný B; Papsuevich OS; Chipens GI; Ermisch A; Barth T
    Endocrinol Exp; 1989 Mar; 23(1):37-42. PubMed ID: 2714226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a highly sensitive LC-MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child.
    Zhang D; Rios DR; Tam VH; Chow DS
    J Pharm Biomed Anal; 2014 Oct; 99():67-73. PubMed ID: 25072843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma concentration of arginine-vasopressin in renal insufficiency is not caused by nonspecific binding of metabolic breakdown products.
    Bald M; Gross P; Rascher W
    Nephron; 1991; 59(3):520-1. PubMed ID: 1758556
    [No Abstract]   [Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of arginine-containing peptides in biological fluids by means of a selective post-column reaction with fluorescence detection.
    Rhodes GR; Boppana VK
    J Chromatogr; 1988 Jul; 444():123-31. PubMed ID: 3204127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet fraction arginine-vasopressin. Potential physiological role.
    Bichet DG; Arthus MF; Barjon JN; Lonergan M; Kortas C
    J Clin Invest; 1987 Mar; 79(3):881-7. PubMed ID: 2950136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin blood flow reduction induced by cigarette smoking: role of vasopressin.
    Waeber B; Schaller MD; Nussberger J; Bussien JP; Hofbauer KG; Brunner HR
    Am J Physiol; 1984 Dec; 247(6 Pt 2):H895-901. PubMed ID: 6548876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocratic high-performance liquid chromatography-photodiode-array detection method for determination of lysine- and arginine-vasopressins and oxytocin in biological samples.
    Rao PS; Weinstein GS; Wilson DW; Rujikarn N; Tyras DH
    J Chromatogr; 1991 Jan; 536(1-2):137-42. PubMed ID: 2050761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position.
    Sawyer WH; Lammek B; Misicka A; Kruszynski M; Kolodzieczyk A; Manning M
    Experientia; 1991 Jan; 47(1):83-6. PubMed ID: 1999249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cerebral edema by the vasopressin antagonist d(CH2)5D-Ile2Ile4Ala9AVP in rats with experimental subarachnoid hemorrhage.
    László FA; Varga C; Baláspiri L
    Ann N Y Acad Sci; 1993 Jul; 689():627-9. PubMed ID: 8373062
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension.
    Bussien JP; Waeber B; Nussberger J; Hofbauer KG; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):130-9. PubMed ID: 3767522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constrained refinement based on NOE and chemical shift information: the monomer form of arginine-vasopressin-like insect factor.
    Busetta B; Picard P
    J Pept Sci; 1997; 3(2):133-40. PubMed ID: 9230478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.
    Nicod P; Biollaz J; Waeber B; Goy JJ; Polikar R; Schlapfer J; Schaller MD; Turini GA; Nussberger J; Hofbauer KG
    Br Heart J; 1986 Nov; 56(5):433-9. PubMed ID: 3790379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.